From Lab to Field: On-Site Saliva Drug Testing and The Journey of COSMAS BIOSCIENCE

COSMAS BIOSCIENCE
  • 0.0 (0)
  • Life Sciences

This seven-part series follows COSMAS BIOSCIENCE from the 2021 THC research paper to AI-assisted R&D of D-Free. Explore Grok selection, literature and patent review, fluid and optical simulation, Bayesian optimization, image QC, optical readout, validation planning, and the road ahead. Grok is a development tool, not part of the device. D-Free remains in development; validation and regulatory reviews are ahead. Produced by COSMAS BIOSCIENCE with AI-generated voices. Not sponsored by xAI.

Episodes

  1. 2d ago

    EP 7. What AI-Assisted R&D Means for the Road Ahead

    North American need: approximately 69,000 U.S. overdose deaths (CDC provisional data, 12 months ending January 2026) and 7,146 Canadian opioid deaths (PHAC, 2024). The team’s internal estimate: over 35% improvement in cost and development efficiency. This estimate has not been audited. A global launch is targeted around 2027, subject to approval, alongside the KPEX 2026 exhibition and the Hong-ik In-gan mission.

  2. 2d ago

    EP 6. From Light Signal to Number

    A compact optical reader and app software comparing signals with calibrated cutoffs. Grok supports comparison of signal-processing methods. The final algorithm is selected by measurement and frozen. Requirement–design–test–result traceability and draft validation plans. FDA, Health Canada, and MFDS reviews are still ahead. Screening results are handled as sensitive personal data.

  3. Oct 21

    EP 5. Fewer Experiments with Bayesian Optimization

    Bayesian optimization selects the next experiment. Objectives: low-concentration signal, even fill, low cartridge variation, and manufacturability. Image QC and anomaly detection for bubbles, uneven wetting, and seating errors, with human review. The team reports optimized flow-path geometry after dozens of runs. Run records are to be retained.

  4. Oct 21

    EP 4. Simulating the Cartridge Before Building It

    OpenFOAM, COMSOL (MPh), and Python scripts drafted with Grok and reviewed by engineers. Sample fill, distribution to multiple test zones, reaction time, and optical signal strength. Linked to lab work through design of experiments (DoE). Setups are validated against hand calculations. All scripts, settings, and results are stored for reproducibility.

  5. Oct 21

    EP 3. Reading Hundreds of Papers at Once

    Lateral flow limits: sensitivity, quantification, and multiplexing. Hundreds of documents condensed into a table of design variables, ranges, and sources. Regulatory requirements reflected early in design, with the patent landscape mapped. Every citation is checked against the original by a person. Regulatory and patent judgments are made by qualified experts.

  6. Oct 21

    EP 2. Why the Team Chose Grok

    A task-based comparison of AI tools: large-document handling, working code, step-by-step trade-off reasoning, and API integration. Working rules: source tracing, engineer code review, and decisions based on measurements. Applied across hardware, software, and marketing. This series is not sponsored by xAI. Field app software is validated separately as a fixed version.

  7. Oct 21

    EP 1. From a Research Paper to an AI-Native Startup

    Limits of roadside drug testing: slow lab analysis, subjective strip reading, and urine reflecting past rather than recent use. The 2021 Science Translational Medicine THC study and founder Dr. Hojeong Yu. Founded in February 2024, with AI built into the R&D workflow from day one. Grok is a development tool, not part of the device. D-Free targets, including multi-drug saliva screening in approximately 15 minutes, are design targets pending validation.

  • 7 Episodes

About

This seven-part series follows COSMAS BIOSCIENCE from the 2021 THC research paper to AI-assisted R&D of D-Free. Explore Grok selection, literature and patent review, fluid and optical simulation, Bayesian optimization, image QC, optical readout, validation planning, and the road ahead. Grok is a development tool, not part of the device. D-Free remains in development; validation and regulatory reviews are ahead. Produced by COSMAS BIOSCIENCE with AI-generated voices. Not sponsored by xAI.

Information